Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTiton Regulatory News (TON)

Share Price Information for Titon (TON)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
75.00
Ask:
85.00
Spread: 10.00 (13.333%)
Market Cap: £9.00m
TON Live PriceLast checked at - London Stock Exchange

Intraday Titon Share Chart

Holding(s) in Company

28 Oct 2011 14:58

RNS Number : 0778R
Titon Holdings PLC
28 October 2011
Β 

ο»Ώ

Β 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Titon Holdings PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ΓΌ

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Mrs Amanda Jane Clipsham

4. Full name of shareholder(s) Β (if different from 3.):iv

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

21 October 2011

6. Date on which issuer notified:

27 October 2011

7. Threshold(s) that is/are crossed orreached: vi, vii

Β Below 8%

Β 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 10 pence each

863,579

863,579

843,579

843,579

7.99%

7.99%

GB0008941402

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

Β 

% of voting rights xix, xx

Β 

Β 

Β 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

843,579

7.99%

Β 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Β 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Mrs A Clipsham

15. Contact telephone number:

01732 763262

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLEADEPASXFFFF
Date   Source Headline
1st Jun 20267:00 amRNSAcquisition
30th Apr 20267:00 amRNSInterim results
17th Apr 20267:00 amRNSNotice of Interim Results & Investor Presentation
20th Mar 20267:00 amRNSResult of AGM
19th Mar 20267:00 amRNSAGM Trading Update
23rd Feb 20267:00 amRNS2025 Annual Report and Notice of AGM
15th Jan 20267:00 amRNSAnnual Financial Report
2nd Dec 20257:00 amRNSDirector/PDMR Shareholding
24th Nov 20257:00 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSFull Year Trading Update
29th Sep 20252:18 pmRNSHolding(s) in Company
29th Sep 202512:42 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSHolding(s) in Company
11th Jul 20259:10 amRNSHolding(s) in Company
7th Jul 20259:01 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSUnaudited Interim Results to 31 March 2025
25th Apr 20257:00 amRNSNotice of Interim Results & Investor Presentation
1st Apr 20257:00 amRNSHolding(s) in Company
25th Mar 20253:10 pmRNSResult of AGM
25th Mar 20257:00 amRNSAGM Trading Update
18th Mar 202512:03 pmRNSDirector/PDMR Shareholdings
3rd Mar 20257:00 amRNS2024 Annual Report and Notice of AGM
23rd Jan 20257:00 amRNSAnnual Financial Report
20th Jan 20257:00 amRNSNotice of Results and Investor Presentation
16th Dec 20247:00 amRNSCompletion of Disposal and Update on FY24 Results
29th Oct 20241:46 pmRNSDirector/PDMR Shareholdings
24th Oct 20247:00 amRNSCommencement of Process to Dispose of Korean Ops
3rd Sep 20247:00 amRNSNon-Executive Board Change
19th Jul 20242:05 pmRNSGrant of options and Director/PDMR Shareholding
11th Jul 20247:00 amRNSTrading Update and Board Change
15th May 20247:00 amRNSInterim Results for six months to 31 March 2024
25th Apr 20247:00 amRNSNotice of Interim Results & Investor Presentation
17th Apr 20242:15 pmRNSNotification of Major Holdings
2nd Apr 20242:43 pmRNSHolding(s) in Company
27th Mar 202411:28 amRNSResult of Annual General Meeting
26th Mar 20247:00 amRNSAGM Trading Update
27th Feb 20245:00 pmRNSDirector/PDMR Shareholding
26th Feb 20243:15 pmRNS2023 Annual Financial Report and Notice of AGM
25th Jan 20247:00 amRNSAnnual Financial Report year ended 30 Sept 2023
19th Jan 20241:07 pmRNSInvestor Presentation via Investor Meet Company
22nd Dec 20237:00 amRNSConfirmation of Board Appointment
5th Dec 20237:00 amRNSNotification of Major Holdings
4th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSNon-Executive Director Changes
22nd Nov 20237:00 amRNSAppointment of CEO
6th Oct 20234:00 pmRNSExercise of Options and Total Voting Rights
14th Sep 20233:45 pmRNSHolding(s) in Company
30th Aug 20232:17 pmRNSNotification of Major Holdings
4th Jul 20234:30 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.